News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
493,897 Results
Type
Article (28600)
Company Profile (73)
Press Release (465224)
Multimedia
Podcasts (25)
Webinars (9)
Section
Business (145958)
Career Advice (813)
Deals (24774)
Drug Delivery (54)
Drug Development (55118)
Employer Resources (67)
FDA (13208)
Job Trends (10474)
News (244323)
Policy (22844)
Tag
Academia (1854)
Accelerated approval (4)
Adcomms (9)
Allergies (76)
Alliances (33714)
ALS (61)
Alzheimer's disease (898)
Antibody-drug conjugate (ADC) (58)
Approvals (13276)
Artificial intelligence (184)
Autoimmune disease (11)
Automation (7)
Bankruptcy (209)
Best Places to Work (8318)
BIOSECURE Act (5)
Biosimilars (42)
Biotechnology (57)
Bladder cancer (63)
Brain cancer (20)
Breast cancer (208)
Cancer (1599)
Cardiovascular disease (121)
Career advice (714)
Career pathing (15)
CAR-T (89)
Cell therapy (254)
Cervical cancer (14)
Clinical research (46424)
Collaboration (514)
Compensation (260)
Complete response letters (9)
COVID-19 (1609)
CRISPR (14)
C-suite (182)
Cystic fibrosis (50)
Data (1686)
Decentralized trials (2)
Denatured (17)
Depression (31)
Diabetes (193)
Diagnostics (4535)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (21)
Drug discovery (61)
Drug pricing (55)
Drug shortages (21)
Duchenne muscular dystrophy (62)
Earnings (59644)
Editorial (20)
Employer branding (11)
Employer resources (65)
Events (74593)
Executive appointments (588)
FDA (14254)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (495)
Gene editing (43)
Generative AI (12)
Gene therapy (158)
GLP-1 (454)
Government (3175)
Grass and pollen (3)
Guidances (42)
Healthcare (14446)
Huntington's disease (11)
IgA nephropathy (17)
Immunology and inflammation (47)
Indications (22)
Infectious disease (1683)
Inflammatory bowel disease (89)
Inflation Reduction Act (5)
Influenza (26)
Intellectual property (58)
Interviews (84)
IPO (11460)
IRA (20)
Job creations (2483)
Job search strategy (656)
Kidney cancer (8)
Labor market (13)
Layoffs (231)
Leadership (8)
Legal (4942)
Liver cancer (60)
Lung cancer (240)
Lymphoma (113)
Machine learning (3)
Management (23)
Manufacturing (136)
MASH (54)
Medical device (13279)
Medtech (13283)
Mergers & acquisitions (13694)
Metabolic disorders (470)
Multiple sclerosis (58)
NASH (12)
Neurodegenerative disease (53)
Neuropsychiatric disorders (10)
Neuroscience (1259)
NextGen: Class of 2025 (4677)
Non-profit (3174)
Now hiring (18)
Obesity (234)
Opinion (92)
Ovarian cancer (58)
Pain (66)
Pancreatic cancer (58)
Parkinson's disease (100)
Partnered (15)
Patents (121)
Patient recruitment (89)
Peanut (39)
People (45672)
Pharmaceutical (20)
Pharmacy benefit managers (11)
Phase I (13591)
Phase II (20204)
Phase III (16223)
Pipeline (901)
Policy (63)
Postmarket research (1886)
Preclinical (4694)
Press Release (68)
Prostate cancer (82)
Psychedelics (19)
Radiopharmaceuticals (187)
Rare diseases (216)
Real estate (3914)
Recruiting (22)
Regulatory (16294)
Reports (19)
Research institute (1723)
Resumes & cover letters (104)
Rett syndrome (5)
RNA editing (2)
RSV (20)
Schizophrenia (55)
Series A (79)
Series B (59)
Service/supplier (3)
Sickle cell disease (23)
Special edition (4)
Spinal muscular atrophy (111)
Sponsored (16)
Startups (2503)
Stomach cancer (9)
Supply chain (43)
Tariffs (14)
The Weekly (8)
Vaccines (373)
Venture capitalists (14)
Weight loss (149)
Women's health (17)
Worklife (4)
Date
Today (120)
Last 7 days (563)
Last 30 days (1782)
Last 365 days (23153)
2025 (7360)
2024 (25107)
2023 (29138)
2022 (38629)
2021 (41594)
2020 (40397)
2019 (34389)
2018 (26300)
2017 (23634)
2016 (22615)
2015 (27196)
2014 (20976)
2013 (17425)
2012 (18752)
2011 (19342)
2010 (18207)
Location
Africa (468)
Alabama (23)
Alaska (4)
Arizona (134)
Arkansas (10)
Asia (29285)
Australia (4548)
California (4070)
Canada (1481)
China (400)
Colorado (189)
Connecticut (197)
Delaware (120)
Europe (60140)
Florida (653)
Georgia (137)
Idaho (44)
Illinois (412)
India (18)
Indiana (242)
Iowa (4)
Japan (144)
Kansas (81)
Kentucky (20)
Louisiana (8)
Maine (64)
Maryland (715)
Massachusetts (2978)
Michigan (154)
Minnesota (339)
Mississippi (2)
Missouri (65)
Montana (27)
Nebraska (22)
Nevada (48)
New Hampshire (61)
New Jersey (1352)
New Mexico (13)
New York (1195)
North Carolina (728)
North Dakota (6)
Northern California (1820)
Ohio (146)
Oklahoma (8)
Oregon (24)
Pennsylvania (986)
Puerto Rico (8)
Rhode Island (27)
South America (696)
South Carolina (21)
Southern California (1534)
Tennessee (85)
Texas (633)
United States (16187)
Utah (144)
Virginia (106)
Washington D.C. (42)
Washington State (312)
West Virginia (3)
Wisconsin (50)
493,897 Results for "apyx medical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
April 30, 2025
·
6 min read
Press Releases
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
April 24, 2025
·
1 min read
Press Releases
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
March 13, 2025
·
18 min read
Press Releases
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025
February 27, 2025
·
1 min read
Press Releases
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results
January 14, 2025
·
5 min read
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit.
April 11, 2024
·
3 min read
Press Releases
Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
·
1 min read
Press Releases
Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™
January 6, 2025
·
4 min read
Business
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Apyx Medical Corporation today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
April 25, 2024
·
2 min read
Press Releases
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
November 13, 2024
·
1 min read
1 of 49,390
Next
